Search research articles
Contact Us
Filters
Showing results (11-20 of 46) with videos related to
Page
of 5
Sort By:
Steroids
|
May 29, 2016
Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer
Kaja Skjefstad, Thea Grindstad, Mehrdad Rakaee Khanehkenari, et al.
Frontiers in Oncology
|
May 14, 2023
Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
Erna-Elise Paulsen, Sigve Andersen, Mehrdad Rakaee, et al.
Scientific Reports
|
July 17, 2019
Differential prognostic impact of platelet-derived growth factor receptor expression in NSCLC
Thomas Karsten Kilvaer, Mehrdad Rakaee, Turid Hellevik, et al.
Cancer Immunology, Immunotherapy : CII
|
July 15, 2017
CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases
Erna-Elise Paulsen, Thomas K Kilvaer, Mehrdad Rakaee, et al.
Frontiers in Immunology
|
January 3, 2025
High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC
Dagny Førde, Thomas Kilvær, Mona Irene Pedersen, et al.
Frontiers in Oncology
|
October 13, 2025
Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status
Dagny Førde, Thomas Kilvær, Mona Irene Pedersen, et al.
Steroids
|
December 24, 2017
Corrigendum to "Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer" [Steroids 113 (2016) 5-13]
Kaja Skjefstad, Thea Grindstad, Mehrdad Rakaee Khanehkenari, et al.
Scientific Reports
|
February 5, 2026
CD3<sup>+</sup>RUNX3<sup>+</sup> lymphocyte density; an independent prognostic factor in colon and lung adenocarcinoma but not in lung squamous cell carcinoma
Thomas K Kilvaer, Dagny Førde, Erna-Elise Paulsen, et al.
Scientific Reports
|
January 25, 2019
MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer
Elin Richardsen, Sigve Andersen, Christian Melbø-Jørgensen, et al.
Plos One
|
August 8, 2015
Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers
Thomas K Kilvaer, Mehrdad Rakaee Khanehkenari, Turid Hellevik, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 46) with videos related to
Sort By:
Page
of 5
Steroids
|
May 29, 2016
Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer
Kaja Skjefstad, Thea Grindstad, Mehrdad Rakaee Khanehkenari, et al.
Frontiers in Oncology
|
May 14, 2023
Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
Erna-Elise Paulsen, Sigve Andersen, Mehrdad Rakaee, et al.
Scientific Reports
|
July 17, 2019
Differential prognostic impact of platelet-derived growth factor receptor expression in NSCLC
Thomas Karsten Kilvaer, Mehrdad Rakaee, Turid Hellevik, et al.
Cancer Immunology, Immunotherapy : CII
|
July 15, 2017
CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases
Erna-Elise Paulsen, Thomas K Kilvaer, Mehrdad Rakaee, et al.
Frontiers in Immunology
|
January 3, 2025
High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC
Dagny Førde, Thomas Kilvær, Mona Irene Pedersen, et al.
Frontiers in Oncology
|
October 13, 2025
Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status
Dagny Førde, Thomas Kilvær, Mona Irene Pedersen, et al.
Steroids
|
December 24, 2017
Corrigendum to "Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer" [Steroids 113 (2016) 5-13]
Kaja Skjefstad, Thea Grindstad, Mehrdad Rakaee Khanehkenari, et al.
Scientific Reports
|
February 5, 2026
CD3<sup>+</sup>RUNX3<sup>+</sup> lymphocyte density; an independent prognostic factor in colon and lung adenocarcinoma but not in lung squamous cell carcinoma
Thomas K Kilvaer, Dagny Førde, Erna-Elise Paulsen, et al.
Scientific Reports
|
January 25, 2019
MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer
Elin Richardsen, Sigve Andersen, Christian Melbø-Jørgensen, et al.
Plos One
|
August 8, 2015
Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers
Thomas K Kilvaer, Mehrdad Rakaee Khanehkenari, Turid Hellevik, et al.
Page
of 5